Aytu biopharma announces fda orange book listing of newly issued patent for cotempla xr-odt(r)

Englewood, co / accesswire / march 23, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that its newly issued us patent no. 11,166,947 for cotempla xr-odt® (methylphenidate) extended-release orally disintegrating tablet is now listed in the u.s. food and drug administration (fda) publication, "approved drug products with therapeutic equivalence evaluations", commonly known as the "orange book.
AYTU Ratings Summary
AYTU Quant Ranking